|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenue | ||||
| Cost of sales | ||||
| Gross Profit | ||||
| Operating Expenses | ||||
| General and administrative | ||||
| Sales and marketing | ||||
| Research and development | ||||
| Total Operating Expenses | ||||
| Loss from Operations | ||||
| Other Income (Expense) | ||||
| Gain on investments | ||||
| Interest expense | ||||
| Other expense, net | ||||
| Total Other Income, net | ||||
| Net Loss | ||||
| Unrealized loss on investments | ||||
| Foreign currency translation adjustment | ||||
| Total Comprehensive Loss | ||||
| Net Loss Per Share of Common Stock | ||||
| Basic (in Dollars per share) | ||||
| Diluted (in Dollars per share) | ||||
| Weighted-Average Shares of Common Stock Outstanding | ||||
| Basic (in Shares) | ||||
| Diluted (in Shares) | ||||
Loading...